Abstract:Introduction Cellular senescence – defined as a stable cell-cycle arrest combined with stereotyped phenotypic changes – plays a causal role in a variety of aged-associated lung diseases. Previous work by our groups and others has shown that cellular senescence contributes to the pathobiology of both lung emphysema and lung fibrosis. However, it remains a conundrum on how these different pathological entities share a common pathogenic mechanism, i.e. lung senescent cell accumulation. The mTOR (mechanistic target of rapamycin) pathway has been validated as o,ne of a cell-senescence inducer. We reasoned here that activation of mTORC1 could either promote lung emphysema or fibrosis depending on the specific lung cell types undergoing senescence. Methods We generated mice with conditional deletion of the tuberous sclerosis complex heterodimer TSC1 (a negative mTORC1 regulator) in selected lung cells including fibroblast and SMCs (SM22-TSC1–/–mice), endothelial cells (P-ECs; PDGF-TSC1–/–mice), and alveolar epithelial cells (AECs; SPC-TSC1–/–mice) Mice with conditional and cell-specific TSC1 deletion were generated using the cre-lox strategy. Results Compared with controls, SM22-TSC1–/–mice developed lung fibrosis as assessed by the Ashcroft score but without lung emphysema as assessed by the absence of changes in the mean linear intercept. In contrast, PDGF-TSC1–/–mice developed lung emphysema with no significant associated lung fibrosis whereas SPC-TSC1–/–mice developed both lung emphysema and lung fibrosis, although to a lower extent than SM22TSC1 mice. This occurred together with an increase of the lung protein levels of the senescence markers p16 and p21as well as of the DNA damage marker gH 2 AX in the three mice strains, with p16 being higher in SM22-TSC1–/–mice than in the two other mutant mice. By the phenotypes of the mutant mice, the fibrosis markers Col1A, PAI1, and vimentin Col3, were increased in both SM22 and SPC-TSC1–/–mice whereas Col3 and pSmad3 were increased only in SM22-TSC1–/–mice. As expected TSC1 deletion in targeted cells leads to higher lung levels of p-AktSer-473, p-GSK-3, p-S6K, and p–4E-BP1 after 3 months. To question whether mice with TSC1 deletion in selected cells developed lung alterations due to the induction of cell senescence, we treated the three mutant mouse strains with the senolytic compound ABT263 (50 mg/kg/day) 3 times a week during the 3 weeks following tamoxifen treatment. Treatment with ABT263 efficiently reduced the phenotypic alterations in the three mouse strains. Conclusion Lung mTOR activation may lead to either lung fibrosis or emphysema via senescence of selected lung cells.

Author Correction: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

Author Correction: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

Correction: Lepore Signorile et al. c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer. Cancers 2022, 14, 4840

Mtorc1-Rps15 Axis Contributes to the Mechanisms Underlying Global Translation Reduction During Senescence of Mouse Embryonic Fibroblasts

Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression

Author Correction: HuR Regulates Telomerase Activity Through TERC Methylation

A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses

Integrative Gene Expression Profiling Reveals That Dysregulated Triple Micrornas Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer Via Cotargeting MAPT [Corrigendum]

mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership

A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan

Correction: Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression

Correction: Gupta et al. Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells. Cancers 2023, 15, 2198

MTOR dependent-induction of lung cell senescence leads to lung fibrosis or emphysema

Correction for: miR-926-3p influences myocardial injury in septic mice through regulation of mTOR signaling pathway by targeting TSC1